Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Independent Bank receives regulatory approval for HCB Financial acquisition